Ovation Science Inc. (OVAT.CN)
CAD 0.03
(-14.29%)
CAD 0.03
(-14.29%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 728.99 Thousand CAD | 288.1% |
| 2022 | 187.83 Thousand CAD | 194.69% |
| 2021 | 63.74 Thousand CAD | -55.54% |
| 2020 | 143.38 Thousand CAD | -60.42% |
| 2019 | 362.23 Thousand CAD | -32.4% |
| 2018 | 535.84 Thousand CAD | 60.48% |
| 2017 | 333.9 Thousand CAD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 919.44 Thousand CAD | 8.57% |
| 2024 Q1 | 846.88 Thousand CAD | 16.17% |
| 2023 Q1 | 384.85 Thousand CAD | 104.89% |
| 2023 FY | 728.99 Thousand CAD | 288.1% |
| 2023 Q4 | 728.99 Thousand CAD | -11.61% |
| 2023 Q2 | 616.83 Thousand CAD | 60.28% |
| 2023 Q3 | 824.77 Thousand CAD | 33.71% |
| 2022 Q2 | 109.95 Thousand CAD | -2.84% |
| 2022 Q4 | 187.83 Thousand CAD | 44.91% |
| 2022 FY | 187.83 Thousand CAD | 194.69% |
| 2022 Q3 | 129.62 Thousand CAD | 17.89% |
| 2022 Q1 | 113.16 Thousand CAD | 77.54% |
| 2021 Q2 | 70.35 Thousand CAD | -16.83% |
| 2021 FY | 63.74 Thousand CAD | -55.54% |
| 2021 Q4 | 63.74 Thousand CAD | 42.56% |
| 2021 Q3 | 44.71 Thousand CAD | -36.44% |
| 2021 Q1 | 84.58 Thousand CAD | -41.01% |
| 2020 Q4 | 143.38 Thousand CAD | -13.52% |
| 2020 Q1 | 429.4 Thousand CAD | 18.54% |
| 2020 FY | 143.38 Thousand CAD | -60.42% |
| 2020 Q3 | 165.79 Thousand CAD | -63.81% |
| 2020 Q2 | 458.13 Thousand CAD | 6.69% |
| 2019 FY | 362.23 Thousand CAD | -32.4% |
| 2019 Q4 | 362.23 Thousand CAD | -8.66% |
| 2019 Q3 | 396.57 Thousand CAD | -14.27% |
| 2019 Q1 | 434.2 Thousand CAD | -18.97% |
| 2019 Q2 | 462.58 Thousand CAD | 6.54% |
| 2018 Q1 | 241.21 Thousand CAD | 0.0% |
| 2018 FY | 535.84 Thousand CAD | 60.48% |
| 2018 Q4 | 535.84 Thousand CAD | 3.26% |
| 2018 Q3 | 518.94 Thousand CAD | 13.03% |
| 2018 Q2 | 459.12 Thousand CAD | 90.34% |
| 2017 FY | 333.9 Thousand CAD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Aion Therapeutic Inc. | 2.93 Million CAD | 75.175% |
| Ayurcann Holdings Corp. | 14.31 Million CAD | 94.909% |
| Blueberries Medical Corp. | 470.72 Thousand CAD | -54.866% |
| The BC Bud Corporation | 626 Thousand CAD | -16.452% |
| BioNxt Solutions Inc. | 6.55 Million CAD | 88.871% |
| CordovaCann Corp. | 11.29 Million CAD | 93.544% |
| Christina Lake Cannabis Corp. | 8.5 Million CAD | 91.425% |
| Captor Capital Corp. | 28.76 Million CAD | 97.466% |
| City View Green Holdings Inc. | 3.73 Million CAD | 80.472% |
| 1CM Inc. | 9.42 Million CAD | 92.264% |
| Global Hemp Group Inc. | 5.82 Million CAD | 87.485% |
| Greenway Greenhouse Cannabis Corporation | 21.17 Million CAD | 96.557% |
| IM Cannabis Corp. | 35.11 Million CAD | 97.924% |
| Lobe Sciences Ltd. | 2.45 Million CAD | 70.362% |
| Maple Leaf Green World Inc. | 10.08 Million CAD | 92.769% |
| Mountain Valley MD Holdings Inc. | 258 Thousand CAD | -182.555% |
| Nextleaf Solutions Ltd. | 4.4 Million CAD | 83.445% |
| Pharmadrug Inc. | 2.92 Million CAD | 75.081% |
| Captiva Verde Wellness Corp. | 2.08 Million CAD | 65.103% |
| RAMM Pharma Corp. | 2.83 Million CAD | 74.291% |
| RIV Capital Inc. | 275.63 Million CAD | 99.736% |
| Revive Therapeutics Ltd. | 3.4 Million CAD | 78.584% |
| Red White & Bloom Brands Inc. | 364.63 Million CAD | 99.8% |
| SLANG Worldwide Inc. | 37.58 Million CAD | 98.06% |
| 1933 Industries Inc. | 23.28 Million CAD | 96.869% |
| Red Light Holland Corp. | 3.82 Million CAD | 80.925% |
| Top Strike Resources Corp. | 20.99 Million CAD | 96.528% |
| Xebra Brands Ltd. | 789.95 Thousand CAD | 7.717% |
| Adastra Holdings Ltd. | 17.65 Million CAD | 95.872% |